Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Core / Intermediate Bond · Payden & Rygel Group

Payden Equity Income Fund Payden Equity Income Fund (Adviser Class) (PYVAX)

Ticker PYVAX · · Holdings as of Jul 31, 2026

Expense ratio
1.01%$101/yr per $10k
5-yr return
+9.1%annualized
1-yr return
+11.2%as of Dec 2025
Net assets
$1.1Ball share classes
Holdings
76

Bottom line

Is PYVAX a good fund? The bottom line

PYVAX is a share class of Payden Equity Income Fund, a managed core / intermediate bond mutual fund from Payden & Rygel Group.

It charges 1.01% — about $101 a year on every $10,000 invested, more expensive than 72% of core / intermediate bond funds we track.

It returned +11.2% over one year, +9.1% a year over five years, +9.3% a year over ten (as of Dec 31, 2025, per its prospectus).

With $1.1 billion in net assets and 76 holdings, its largest position is Microsoft Corp (4.7%) and the top 10 make up 30% of the portfolio.

What stands out

  • 5-year return beat 92% of category peers

What to watch

  • Expensive for its category (1.01%)
  • 12b-1 marketing fee of 0.25% a year
  • High turnover (112% a year) can mean more taxable distributions

Updated Nov 19, 2026

What PYVAX invests in

The Fund seeks growth of capital and some current income.

The Fund invests primarily in large-capitalization value stocks, defined as companies with sustainable cash flows and the ability to pay and grow dividends over time. The Fund may also invest in other income-producing equity securities, including preferred stocks, real estate investment trusts, and master limited partnerships. Payden employs a disciplined investment process that combines fundamental analysis and quantitative techniques to construct a portfolio of high-quality companies with durable cash flows. The strategy seeks to generate attractive current income and long-term capital appreciation while exhibiting lower volatility than the broader equity market over a longterm investment horizon. The Funds benchmark is the Russell 1000 Value Index, which is used for performance comparison purposes. The Fund invests in only a portion of the securities included in the benchmark and…

From the fund's prospectus (filed Mar 4, 2026).

PYVAX performance

Fund calendar-year total returns, 2016–2025 2016: +14.6%; 2017: +15.5%; 2018: −7.0%; 2019: +27.6%; 2020: +0.5%; 2021: +22.9%; 2022: −6.9%; 2023: +5.0%; 2024: +15.7%; 2025: +11.2% +15% 2016 +16% 2017 −7% 2018 +28% 2019 +1% 2020 +23% 2021 −7% 2022 +5% 2023 +16% 2024 +11% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
PYVAX+11.2%+9.1%+9.3%
Core / Intermediate Bond median+7.2%+1.4%+3.0%

Source: Fund prospectus, as of Dec 31, 2025

Full PYVAX performance history →

What PYVAX costs

On a $10,000 investment, PYVAX's 1.01% expense ratio costs about $101 a year. The prospectus estimates $1,236 in total costs over 10 years (assuming 5% annual returns). The median core / intermediate bond fund charges 0.71%.

See the full PYVAX fee table →

PYVAX top 10 holdings

#Holding% of fund
1Microsoft Corp MSFT4.73%
2Amazon.com Inc AMZN4.24%
3Apple Inc AAPL3.76%
4Jp Morgan Chase & Company JPM3.31%
5Alphabet Inc GOOGL2.79%
6Morgan Stanley MS2.73%
7Merck & Company Inc MRK2.22%
8Rtx Corp RTX2.16%
9Cisco Systems Inc CSCO2.10%
10Duke Energy Corp DUK1.94%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 30% of the fund. See all top 25 holdings and asset mix →

Alternatives to PYVAX

More funds like PYVAX →

PYVAX FAQ

What is the expense ratio of PYVAX?
PYVAX's expense ratio is 1.01%, which works out to about $101 a year for every $10,000 invested. The prospectus estimates total costs of $1,236 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is PYVAX a good investment?
It depends on your goals, but the data points to: 5-year return beat 92% of category peers; expensive for its category (1.01%); 12b-1 marketing fee of 0.25% a year; high turnover (112% a year) can mean more taxable distributions. This is general information, not personalized advice.
What does PYVAX hold?
PYVAX's largest holdings are Microsoft Corp (4.7%), Amazon.com Inc (4.2%), Apple Inc (3.8%), Jp Morgan Chase & Company (3.3%), Alphabet Inc (2.8%). It holds 76 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is PYVAX's 5-year return?
PYVAX returned +9.1% a year over the five years ending Dec 31, 2025, and +9.3% a year over ten years. Past performance does not guarantee future results.
Who manages PYVAX?
PYVAX is offered by Payden & Rygel Group through Payden & Rygel Investment Group.